Aksoy, S. Et Al. 2010. Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?. JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15 .

Aksoy, S., Arslan, C., Kurt, M., Dizdar, O., Dede, D. S., Dogan, E., ... Gullu, İ. H.(2010). Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?. JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15.

Aksoy, S. Et Al. "Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?," JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15, 2010

Aksoy, S. Et Al. "Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?." JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15, 2010

Aksoy, S. Et Al. (2010) . "Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?." JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15.

@article{article, author={S. Aksoy Et Al. }, title={Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit?}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2010}